eXoZymes to receive $3M from NSF as key partner in $9.2M cell-free biomanufacturing initiative

EXOZYMES INC.

Selected as core industrial partner in Meta-PURE, a $9.2M NSF-funded project under CFIRE program.
eXoZymes awarded approximately $3M share to develop a cell-free ATP-generating module and a santalene production module.
Project led by Georgia Tech; coalition includes academic and industry groups; starts July 1, 2025, for three years.
eXoZymes' technology enables plug-and-play modular cell-free biomanufacturing for multiple market-relevant targets.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.